Article Information
History
- September 21, 2022.
Article Versions
- You are currently viewing Version 1 of this article (September 21, 2022 - 11:06).
- Version 2 (October 17, 2022 - 13:18).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Dr. Gayatri Devi Yellapu1,
- Gowrisree Rudraraju*,2,
- Narayana Rao Sripada2,
- Baswaraj Mamidgi2,
- Charan Jalukuru2,
- Priyanka Firmal2,
- Venkat Yechuri2,
- Dr. Sowmya Varanasi1,
- Dr. Peddireddi Venkata Sudhakar1,
- Dr. Devi Madhavi Bhimarasetty1,
- Dr. Sidharth Kanisetti1,
- Dr. Niranjan Joshi3,
- Dr Prasant Mahapatra4 and
- Dr. kiran Pamarthi1
- 1Andhra Medical College, Visakhapatnam, India
- 2Salcit Technologies, Jayabheri Silicon Towers, Hyderabad India
- 3C-CAMP, Department of Biotechnology, Government of India
- 4Department of Computer Science, University of California, Davis
- ↵*Corresponding author: gowri{at}salcit.in
Posted September 21, 2022.
Development and Clinical Validation of Swaasa AI Platform for screening and prioritization of Pulmonary TB
